Signaling pathways in ischemic preconditioning

Heart Failure Reviews

Volumn 12, Issue 3-4, 2007, Pages 181-188

  Downey, James M ^a   Davis, Amanda M ^a   Cohen, Michael V ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Akt; Gi protein coupled receptors; Mitochondrial permeability transition pore; Nitric oxide; PI3 kinase; PKC; Preconditioning; Reactive oxygen species

Indexed keywords

ADENOSINE A2 RECEPTOR; ADENOSINE TRIPHOSPHATE; BRADYKININ; EPIDERMAL GROWTH FACTOR RECEPTOR; GUANYLATE CYCLASE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OPIATE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE; PROTEIN KINASE B; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; AKTIP PROTEIN, HUMAN; APOPTOSIS REGULATORY PROTEIN; CARRIER PROTEIN; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CHANNEL GATING; ENZYME ACTIVATION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; ISCHEMIC PRECONDITIONING; MITOCHONDRIAL PERMEABILITY; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REPERFUSION; SIGNAL TRANSDUCTION; TRANSACTIVATION; HEART MUSCLE REPERFUSION; METHODOLOGY; PATHOPHYSIOLOGY; REVIEW;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS REGULATORY PROTEINS; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 35848968042     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10741-007-9025-2     Document Type: Article

References (78)

1. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136
2. 1 adenosine receptors in rabbit heart. Circulation 84:350-356
3. Wall TM, Sheehy R, Hartman JC (1994) Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther 270:681-689
4. Schultz JEJ, Rose E, Yao Z, Gross GJ (1995) Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 268:H2157-H2161
5. Goto M, Liu Y, Yang X-M, Ardell JL, Cohen MV, Downey JM (1995) Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77:611-621
6. Miki T, Cohen MV, Downey JM (1998) Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem 186:3-12
7. Baines CP, Goto M, Downey JM (1997) Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 29:207-216
8. 1 receptor activation is abolished by protein kinase C inhibitors in the rabbit. Cardiovasc Res 29:682-688
9. 1-adrenergic mechanism. Circ Res 73:656-670
10. Liu Y, Tsuchida A, Cohen MV, Downey JM (1995) Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol 27:883-892
11. Wang P, Gallagher KP, Downey JM, Cohen MV (1996) Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart. J Mol Cell Cardiol 28:579-588
12. ATP channels triggers the preconditioned state by generating free radicals. Circ Res 87:460-466
13. Van Winkle DM, Thornton JD, Downey DM, Downey JM (1991) The natural history of preconditioning: Cardioprotection depends on duration of transient ischemia and time to subsequent ischemia. Coron Artery Dis 2:613-619
14. Krenz M, Oldenburg O, Wimpee H, Cohen MV, Garlid KD, Critz SD et al (2002) Opening of ATP-sensitive potassium channels causes generation of free radicals in vascular smooth muscle cells. Basic Res Cardiol 97:365-373
15. ATP channel opening. J Mol Cell Cardiol 35:653-660
16. i proteins, phosphatidylinositol 3-kinase and tyrosine kinase. Cardiovasc Res 55:544-552
17. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C et al (1999) EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402:884-888
18. Krieg T, Cui L, Qin Q, Cohen MV, Downey JM (2004) Mitochondrial ROS generation following acetylcholine-induced EGF receptor transactivation requires metalloproteinase cleavage of proHB-EGF. J Mol Cell Cardiol 36:435-443
19. Krieg T, Qin Q, McIntosh EC, Cohen MV, Downey JM (2002) ACh and adenosine activate PI3-kinase in rabbit hearts through transactivation of receptor tyrosine kinases. Am J Physiol 283:H2322-H2330
20. Cohen MV, Philipp S, Krieg T, Cui L, Kuno A, Solodushko V et al (2007) Preconditioning-mimetics bradykinin and DADLE activate PI3-kinase through divergent pathways. J Mol Cell Cardiol 42:842-851
21. Qin Q, Downey JM, Cohen MV (2003) Acetylcholine but not adenosine triggers preconditioning through PI3-kinase and a tyrosine kinase. Am J Physiol 284:H727-H734
22. ATP channels. Circ Res 89:273-278
23. Tong H, Chen W, Steenbergen C, Murphy E (2000) Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res 87:309-315
24. Mocanu MM, Bell RM, Yellon DM (2002) PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. J Mol Cell Cardiol 34:661-668
25. Andjelković M, Alessi DR, Meier R, Fernandez A, Lamb NJC, Frech M et al (1997) Role of translocation in the activation and function of protein kinase B. J Biol Chem 272:31515-31524
26. Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB et al (1998) Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279:710-714
27. Krieg T, Qin Q, Philipp S, Alexeyev MF, Cohen MV, Downey JM (2004) Acetylcholine and bradykinin trigger preconditioning in the heart through a pathway that includes Akt and NOS. Am J Physiol 287:H2606-H2611
28. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601-605
29. Bolli R, Dawn B, Tang X-L, Qiu Y, Ping P, Xuan Y-T et al (1998) The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol 93:325-338
30. Lochner A, Marais E, Genade S, Moolman JA (2000) Nitric oxide: A trigger for classic preconditioning? Am J Physiol 279:H2752-H2765
31. Oldenburg O, Qin Q, Krieg T, Yang X-M, Philipp S, Critz SD et al (2004) Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoK ATP channel opening and leads to cardioprotection. Am J Physiol 286:H468-H476
32. Cohen MV, Yang X-M, Downey JM (2006) Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies. Cardiovasc Res 70:231-239
33. Nakano A, Liu GS, Heusch G, Downey JM, Cohen MV (2000) Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol 32:1159-1167
34. Qin Q, Yang X-M, Cui L, Critz SD, Cohen MV, Browner NC et al (2004) Exogenous NO triggers preconditioning via a cGMP- and mitoK ATP-dependent mechanism. Am J Physiol 287:H712-H718
35. Yang X-M, Philipp S, Downey JM, Cohen MV (2006) Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts. Basic Res Cardiol 101:311-318
36. Costa ADT, Garlid KD, West IC, Lincoln TM, Downey JM, Cohen MV et al (2005) Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res 97:329-336
37. Forbes RA, Steenbergen C, Murphy E (2001) Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res 88:802-809
38. Tritto I, D'Andrea D, Eramo N, Scognamiglio A, De Simone C, Violante A et al (1997) Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res 80:743-748
39. Korichneva I, Hoyos B, Chua R, Levi E, Hammerling U (2002) Zinc release from protein kinase C as the common event during activation by lipid second messenger or reactive oxygen. J Biol Chem 277:44327-44331
40. Heinzel FR, Luo Y, Li X, Boengler K, Buechert A, García-Dorado D et al (2005) Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ Res 97:583-586
41. Murry CE, Jennings RB, Reimer KA (1991) New insights into potential mechanisms of ischemic preconditioning. Circulation 84:442-445
42. Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM (2005) Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol 288:H971-H976
43. ATP channels in the isolated rabbit heart. Basic Res Cardiol 94:188-198
44. Xu Z, Yang X-M, Cohen MV, Neumann T, Heusch G, Downey JM (2000) Limitation of infarct size in rabbit hearts by the novel adenosine receptor agonist AMP 579 administered at reperfusion. J Mol Cell Cardiol 32:2339-2347
45. Baxter GF, Mocanu MM, Brar BK, Latchman DS, Yellon DM (2001) Cardioprotective effects of transforming growth factor-β1 during early reoxygenation or reperfusion are mediated by p42/p44 MAPK. J Cardiovasc Pharmacol 38:930-939
46. Schulman D, Latchman DS, Yellon DM (2002) Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway. Am J Physiol 283:H1481-H1488
47. Liao Z, Brar BK, Cai Q, Stephanou A, O'Leary RM, Pennica D et al (2002) Cardiotrophin-1 (CT-1) can protect the adult heart from injury when added both prior to ischaemia and at reperfusion. Cardiovasc Res 53:902-910
48. Zhang SJ, Yang X-M, Liu GS, Cohen MV, Pemberton K, Downey JM (2003) CGX-1051, a peptide from Conus snail venom, attenuates infarction in rabbit hearts when administered at reperfusion. J Cardiovasc Pharmacol 42:764-771
49. Yang X-M, Krieg T, Cui L, Downey JM, Cohen MV (2004) NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO. J Mol Cell Cardiol 36:411-421
50. Cai Z, Semenza GL (2004) Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury. Circulation 109:2050-2053
51. Parsa CJ, Kim J, Riel RU, Pascal LS, Thompson RB, Petrofski JA et al (2004) Cardioprotective effects of erythropoietin in the reperfused ischemic heart: A potential role for cardiac fibroblasts. J Biol Chem 279:20655-20662
52. Solenkova NV, Solodushko V, Cohen MV, Downey JM (2006) Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt. Am J Physiol 290:H441-H449
53. 2b receptor cascade. Cardiovasc Res 70:308-314
54. Vinten-Johansen J, Thourani VH, Ronson RS, Jordan JE, Zhao Z-Q, Nakamura M et al (1999) Broad-spectrum cardioprotection with adenosine. Ann Thorac Surg 68:1942-1948
55. Hausenloy DJ, Yellon DM, Mani-Babu S, Duchen MR (2004) Preconditioning protects by inhibiting the mitochondrial permeability transition. Am J Physiol 287:H841-H849
56. Halestrap AP, Clarke SJ, Javadov SA (2004) Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res 61:372-385
57. Zhao Z-Q, Vinten-Johansen J (2002) Myocardial apoptosis and ischemic preconditioning. Cardiovasc Res 55:438-455
58. Tong H, Imahashi K, Steenbergen C, Murphy E (2002) Phosphorylation of glycogen synthase kinase-3β during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective. Circ Res 90:377-379
59. Juhaszova M, Zorov DB, Kim S-H, Pepe S, Fu Q, Fishbein KW et al (2004) Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113:1535-1549
60. Xu Z, Downey JM, Cohen MV (2003) Timing and duration of administration are crucial for antiinfarct effect of AMP 579 infused at reperfusion in rabbit heart. Heart Dis 5:368-371
61. Bullard AJ, Govewalla P, Yellon DM (2005) Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo. Basic Res Cardiol 100:397-403
62. Salloum FN, Takenoshita Y, Ockaili RA, Daoud VP, Chou E, Yoshida K-i et al (2007) Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K ATP channels when administered at reperfusion following ischemia in rabbits. J Mol Cell Cardiol 42:453-458
63. Asakura M, Jiyoong K, Minamino T, Shintani Y, Asanuma H, Kitakaze M (2004) Rationale and design of a large-scale trial using atrial natriuretic peptide (ANP) as an adjunct to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction: Japan-Working groups of acute myocardial Infarction for the reduction of Necrotic Damage by ANP (J-WIND-ANP). Circ J 68:95-100
64. Minamino T, Jiyoong K, Asakura M, Shintani Y, Asanuma H, Kitakaze M (2004) Rationale and design of a large-scale trial using nicorandil as an adjunct to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction: Japan-Working groups of acute myocardial Infarction for the reduction of Necrotic Damage by a K-ATP channel opener (J-WIND-KATP). Circ J 68:101-106
65. Ohno Y, Minatoguchi S, Uno Y, Kariya T, Arai M, Yamashita K et al (1997) Nicorandil reduces myocardial infarct size by opening the K ATP channel in rabbits. Int J Cardiol 62:181-190
66. Imagawa J-i, Baxter GF, Yellon DM (1998) Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo. J Cardiovasc Pharmacol 31:74-79
67. Das B, Sarkar C, Karanth KS (2001) Effects of administration of nicorandil or bimakalim prior to and during ischemia or reperfusion on survival rate, ischemia/reperfusion-induced arrhythmias and infarct size in anesthetized rabbits. Naunyn Schmiedebergs Arch Pharmacol 364:383-396
68. ATP activators during ischemia and reperfusion in an intact anesthetized rabbit model. Pol J Pharmacol 55:771-786
69. ATP channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model? Life Sci 77:1226-1248
70. D'Souza SP, Yellon DM, Martin C, Schulz R, Heusch G, Onody A et al (2003) B-type natriuretic peptide limits infarct size in rat isolated hearts via K ATP channel opening. Am J Physiol 284:H1592-H1600
71. D'Souza SP, Davis M, Baxter GF (2004) Autocrine and paracrine actions of natriuretic peptides in the heart. Pharmacol Ther 101:113-129
72. Jonassen AK, Brar BK, Mjøs OD, Sack MN, Latchman DS, Yellon DM (2000) Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism. J Mol Cell Cardiol 32:757-764
73. Jonassen AK, Aasum E, Riemersma RA, Mjøs OD, Larsen TS (2000) Glucose-insulin-potassium reduces infarct size when administered during reperfusion. Cardiovasc Drugs Ther 14:615-623
74. Mehta SR, Yusuf S, Diaz R, Zhu J, Pais P, Xavier D et al (2005) Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: The CREATE-ECLA randomized controlled trial. JAMA 293:437-446
75. Vander Heide RS, Reimer KA (1996) Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs. Cardiovasc Res 31:711-718
76. 2 receptors. J Cardiovasc Pharmacol 38:474-481
77. Mahaffey KW, Puma JA, Barbagelata NA, DiCarli MF, Leesar MA, Browne KF et al (1999) Adenosine as an adjunct to thrombolytic therapy for actue myocardial infarction. Results of a multicenter, randomized, placebo-controlled trial: The Acute Myocardial Infarction STudy of ADenosine (AMISTAD) Trial. J Am Coll Cardiol 34:1711-1720
78. Ross AM, Gibbons RJ, Stone GW, Kloner RA, Alexander RW (2005) A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of actue myocardial infarction (AMISTAD-II). J Am Coll Cardiol 45:1775-1780